| Product Code: ETC12192366 | Publication Date: Apr 2025 | Updated Date: Apr 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
In 2024, Ireland continued to rely on key exporters such as the USA, UK, Germany, Metropolitan France, and Serbia for its follicle-stimulating hormone imports. Despite a high Herfindahl-Hirschman Index indicating market concentration, the compound annual growth rate (CAGR) for 2020-24 was negative at -4.18%. The growth rate from 2023-24 further declined significantly by -30.16%, reflecting a challenging market environment for follicle-stimulating hormone imports in Ireland.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Ireland Follicle-Stimulating Hormone Market Overview |
3.1 Ireland Country Macro Economic Indicators |
3.2 Ireland Follicle-Stimulating Hormone Market Revenues & Volume, 2022 & 2032F |
3.3 Ireland Follicle-Stimulating Hormone Market - Industry Life Cycle |
3.4 Ireland Follicle-Stimulating Hormone Market - Porter's Five Forces |
3.5 Ireland Follicle-Stimulating Hormone Market Revenues & Volume Share, By Type, 2022 & 2032F |
3.6 Ireland Follicle-Stimulating Hormone Market Revenues & Volume Share, By Form, 2022 & 2032F |
3.7 Ireland Follicle-Stimulating Hormone Market Revenues & Volume Share, By Application, 2022 & 2032F |
3.8 Ireland Follicle-Stimulating Hormone Market Revenues & Volume Share, By End User, 2022 & 2032F |
3.9 Ireland Follicle-Stimulating Hormone Market Revenues & Volume Share, By Dosage, 2022 & 2032F |
4 Ireland Follicle-Stimulating Hormone Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness and diagnosis of reproductive health issues in Ireland |
4.2.2 Growing prevalence of infertility cases in the country |
4.2.3 Technological advancements leading to the development of more efficient FSH products |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for FSH products in Ireland |
4.3.2 High cost associated with FSH treatment |
4.3.3 Limited reimbursement policies for fertility treatments in the country |
5 Ireland Follicle-Stimulating Hormone Market Trends |
6 Ireland Follicle-Stimulating Hormone Market, By Types |
6.1 Ireland Follicle-Stimulating Hormone Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Ireland Follicle-Stimulating Hormone Market Revenues & Volume, By Type, 2022 - 2032F |
6.1.3 Ireland Follicle-Stimulating Hormone Market Revenues & Volume, By Recombinant FSH, 2022 - 2032F |
6.1.4 Ireland Follicle-Stimulating Hormone Market Revenues & Volume, By Urinary-Derived FSH, 2022 - 2032F |
6.1.5 Ireland Follicle-Stimulating Hormone Market Revenues & Volume, By Human FSH, 2022 - 2032F |
6.1.6 Ireland Follicle-Stimulating Hormone Market Revenues & Volume, By Synthetic FSH, 2022 - 2032F |
6.2 Ireland Follicle-Stimulating Hormone Market, By Form |
6.2.1 Overview and Analysis |
6.2.2 Ireland Follicle-Stimulating Hormone Market Revenues & Volume, By Injection, 2022 - 2032F |
6.2.3 Ireland Follicle-Stimulating Hormone Market Revenues & Volume, By Powder, 2022 - 2032F |
6.2.4 Ireland Follicle-Stimulating Hormone Market Revenues & Volume, By Liquid, 2022 - 2032F |
6.2.5 Ireland Follicle-Stimulating Hormone Market Revenues & Volume, By Tablet, 2022 - 2032F |
6.3 Ireland Follicle-Stimulating Hormone Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 Ireland Follicle-Stimulating Hormone Market Revenues & Volume, By Fertility Treatment, 2022 - 2032F |
6.3.3 Ireland Follicle-Stimulating Hormone Market Revenues & Volume, By IVF Procedures, 2022 - 2032F |
6.3.4 Ireland Follicle-Stimulating Hormone Market Revenues & Volume, By Ovulation Induction, 2022 - 2032F |
6.3.5 Ireland Follicle-Stimulating Hormone Market Revenues & Volume, By Hormone Replacement Therapy, 2022 - 2032F |
6.4 Ireland Follicle-Stimulating Hormone Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Ireland Follicle-Stimulating Hormone Market Revenues & Volume, By Hospitals, 2022 - 2032F |
6.4.3 Ireland Follicle-Stimulating Hormone Market Revenues & Volume, By Fertility Clinics, 2022 - 2032F |
6.4.4 Ireland Follicle-Stimulating Hormone Market Revenues & Volume, By Gynecology Centers, 2022 - 2032F |
6.4.5 Ireland Follicle-Stimulating Hormone Market Revenues & Volume, By Pharmaceutical Companies, 2022 - 2032F |
6.5 Ireland Follicle-Stimulating Hormone Market, By Dosage |
6.5.1 Overview and Analysis |
6.5.2 Ireland Follicle-Stimulating Hormone Market Revenues & Volume, By 75 IU-150 IU, 2022 - 2032F |
6.5.3 Ireland Follicle-Stimulating Hormone Market Revenues & Volume, By 225 IU-450 IU, 2022 - 2032F |
6.5.4 Ireland Follicle-Stimulating Hormone Market Revenues & Volume, By 50 IU-100 IU, 2022 - 2032F |
6.5.5 Ireland Follicle-Stimulating Hormone Market Revenues & Volume, By 10 mg-50 mg, 2022 - 2032F |
7 Ireland Follicle-Stimulating Hormone Market Import-Export Trade Statistics |
7.1 Ireland Follicle-Stimulating Hormone Market Export to Major Countries |
7.2 Ireland Follicle-Stimulating Hormone Market Imports from Major Countries |
8 Ireland Follicle-Stimulating Hormone Market Key Performance Indicators |
8.1 Average age of women seeking fertility treatments in Ireland |
8.2 Number of fertility clinics offering FSH treatment in the market |
8.3 Adoption rate of advanced FSH products in the country |
9 Ireland Follicle-Stimulating Hormone Market - Opportunity Assessment |
9.1 Ireland Follicle-Stimulating Hormone Market Opportunity Assessment, By Type, 2022 & 2032F |
9.2 Ireland Follicle-Stimulating Hormone Market Opportunity Assessment, By Form, 2022 & 2032F |
9.3 Ireland Follicle-Stimulating Hormone Market Opportunity Assessment, By Application, 2022 & 2032F |
9.4 Ireland Follicle-Stimulating Hormone Market Opportunity Assessment, By End User, 2022 & 2032F |
9.5 Ireland Follicle-Stimulating Hormone Market Opportunity Assessment, By Dosage, 2022 & 2032F |
10 Ireland Follicle-Stimulating Hormone Market - Competitive Landscape |
10.1 Ireland Follicle-Stimulating Hormone Market Revenue Share, By Companies, 2025 |
10.2 Ireland Follicle-Stimulating Hormone Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here